Product Details
This product is not currently available, please contact us for further information.
Product Properties:
| Description | - |
|---|---|
| Description | S |
| Description | S |
| DESI Drug Ind | -; - |
| DESI Drug Ind | -; - |
| DESI Drug Ind | - |
| DESI2 Drug Ind | - |
| Drug Category | USES: Abrocitinib is used to treat a certain moderate-to-severe skin rash (dermatitis) that is not controlled with other treatments. Abrocitinib belongs to a class of drugs known as Janus kinase (JAK) inhibitors. |
| Drug Category | S |
| Drug Category | USES: Abrocitinib is used to treat a certain moderate-to-severe skin rash (dermatitis) that is not controlled with other treatments. Abrocitinib belongs to a class of drugs known as Janus kinase (JAK) inhibitors. |
| Drug Type Code | 1 |
| Drug Type Code | COMMON BRAND NAME(S): Cibinqo |
| Drug Type Code | COMMON BRAND NAME(S): Cibinqo |
| FDA Approval Date | 04/23/2021 |
| FDA Therap Equiv | NR |
| HCPCS | - |
| HCPCS | 1 |
| HCPCS | 1 |
| Market Entry Date | 02/23/2022 |
| Medical Coverage | - |
| Medical Coverage | - |
| Medical Coverage | - |
| Termination Date | (A-broe-SYE-ti-nib) |
| Termination Date | - |
| Termination Date | (A-broe-SYE-ti-nib) |
| Unit | TAB |
| Units Per Pkg | 1 |
| Active Ingredients | 18933 abrocitinib |
| Active Ingredients | 18933 abrocitinib |
| Active Ingredients | 18933 abrocitinib |
| AHFS Class | 92360000 DISEASE-MODIFYING ANTIRHEUMATIC AGENTS; 92200000 IMMUNOMODULATORY AGENTS |
| AHFS Class | 92360000 DISEASE-MODIFYING ANTIRHEUMATIC AGENTS; 92200000 IMMUNOMODULATORY AGENTS |
| AHFS Class | 92360000 DISEASE-MODIFYING ANTIRHEUMATIC AGENTS; 92200000 IMMUNOMODULATORY AGENTS |
| DEA Class | NC |
| DEA Class | NC |
| DEA Class | NC |
| Dose Form | TABLET |
| Dose Form | TABLET |
| Dose Form | TABLET |
| Fine Line Class | 850085008510 All Rx Products |
| Fine Line Class | 850085008510 All Rx Products |
| Fine Line Class | 850085008510 All Rx Products |
| Gen Code and Des | 82990 abrocitinib ORAL TABLET 100 MG |
| Gen Code and Des | 82990 abrocitinib ORAL TABLET 100 MG |
| Gen Code and Des | 82990 abrocitinib ORAL TABLET 100 MG |
| Inactive Ingredients | 2432 lactose 64044515 |
| Inactive Ingredients | 2432 lactose 64044515 |
| Inactive Ingredients | 2432 lactose 64044515 |
| OMP Family | - |
| OMP Family | - |
| OMP Family | - |
| Product Category | RX Pharmaceuticals |
| Product Category | RX Pharmaceuticals |
| Product Category | RX Pharmaceuticals |
| Strength | 100MG |
| Strength | 100MG |
| Strength | 100MG |
| Common Brand Name | - |
| Common Brand Name | COMMON BRAND NAME(S): Cibinqo |
| Common Brand Name | - |
| Drug Interaction | DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval. A product that may interact with this drug is: fluconazole. During the first three months of treatment, avoid taking drugs that may increase the risk of bleeding. However, if your doctor has directed you to take low-dose aspirin for heart attack or stroke prevention (usually 81-162 milligrams a day), you should continue taking it unless your doctor instructs you otherwise. Ask your doctor or pharmacist for more details. |
| Drug Interaction | - |
| Drug Interaction | - |
| Allocation Period | - |
| Allocation Period | - |
| Allocation Period | - |
| Case Quantity | 48 |
| Case Quantity | 48 |
| Case Quantity | 48 |
| Drug Form Pack Size | 30 |
| Drug Form Pack Size | 30 |
| Drug Form Pack Size | 30 |
| Form | TABLET |
| Form | TABLET |
| Form | TABLET |
| Hazard Code | UN3077 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. |
| Hazard Code | UN3077 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. |
| Hazard Code | UN3077 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. |
| Listed Chemical | - |
| Listed Chemical | - |
| Listed Chemical | - |
| NIOSH Code | - |
| NIOSH Code | - |
| NIOSH Code | - |
| Orange Book | ZC Pharmaceutical entity and labeler evaluated but no therapeutic equivalence rating given. Usually applies to single source drugs. |
| Orange Book | ZC Pharmaceutical entity and labeler evaluated but no therapeutic equivalence rating given. Usually applies to single source drugs. |
| Orange Book | ZC Pharmaceutical entity and labeler evaluated but no therapeutic equivalence rating given. Usually applies to single source drugs. |
| Retail Pack Quantity | 1 |
| Retail Pack Quantity | 1 |
| Retail Pack Quantity | 1 |
| Returnable Status | Returnable |
| Returnable Status | Returnable |
| Returnable Status | Returnable |
| Special Storage Cond | 00 None |
| Special Storage Cond | 00 None |
| Special Storage Cond | 00 None |
| Temp Zone | 10 Room Temperature |
| Temp Zone | 10 Room Temperature |
| Temp Zone | 10 Room Temperature |
| Unit | EA |
| Unit | EA |
| Unit | EA |
| Unit Size | 30 |
| Unit Size | 30 |
| Unit Size | 30 |
| How to Use | - |
| How to Use | - |
| How to Use | HOW TO USE: Read the Medication Guide provided by your pharmacist before you start taking abrocitinib and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Take this medication by mouth with or without food as directed by your doctor, usually once daily. The manufacturer directs not to crush, split, or chew the tablet before taking it. However, many similar drugs (immediate-release tablets) can be split, crushed, or chewed. Follow your doctor's directions on how to take this medication. The dosage is based on your medical condition, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Do not increase your dose or use this drug more often or for longer than prescribed. Your condition will not improve any faster, and your risk of serious side effects will increase. Take this medication regularly to get the most benefit from it. Remember to take it at the same time each day. Tell your doctor if your condition does not get better or if it gets worse. |
| Missed Dose | 1 |
| Missed Dose | 1 |
| Missed Dose | MISSED DOSE: If you miss a dose, take it as soon as you remember. If it is less than 12 hours before the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up. |
| Notes | NOTES: Do not share this medication with others. Lab and/or medical tests (such as complete blood count, kidney/liver function, cholesterol levels, skin exams) should be done while you are using this medication. Keep all medical and lab appointments. |
| Notes | TAB |
| Notes | TAB |
| Overdose | NR |
| Overdose | NR |
| Overdose | OVERDOSE: If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center. |
| Phonetic Pronunciation | - |
| Phonetic Pronunciation | - |
| Phonetic Pronunciation | (A-broe-SYE-ti-nib) |
| Precautions | PRECAUTIONS: See also Warning section. Before taking abrocitinib, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: blood clots (such as in the lungs, legs), blood/bone marrow disorders (such as anemia, low blood cell count), cancer, eye problems (such as cataracts, retinal detachment), heart problems (such as previous heart attack), kidney disease, liver disease (such as hepatitis B or C), past/recent/current infections (such as tuberculosis, herpes zoster, HIV infection), current or past smoking, stroke. This drug may make you dizzy. Alcohol or marijuana (cannabis) can make you more dizzy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis). Abrocitinib can make you more likely to get infections or may make current infections worse. Stay away from anyone who has an infection that may easily spread (such as chickenpox, COVID-19, measles, flu). Talk to your doctor if you have been exposed to an infection or for more details. Tell your health care professional that you are using abrocitinib before having any immunizations/vaccinations. Avoid contact with people who have recently received live vaccines (such as flu vaccine inhaled through the nose). This medication may increase your risk of developing skin cancer. Limit your time in the sun. Avoid tanning booths and sunlamps. Use sunscreen and wear protective clothing when outdoors. Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). During pregnancy, this medication should be used only when clearly needed. It may harm an unborn baby. Discuss the risks and benefits with your doctor. It is unknown if this medication passes into breast milk. However, because of the possible risk to the infant, breast-feeding while using this drug and for at least 1 day after the last dose is not recommended. Consult your doctor before breast-feeding. |
| Precautions | - |
| Precautions | - |
| Side Effects | - |
| Side Effects | - |
| Side Effects | SIDE EFFECTS: See also Warning section. Nausea, headache, dizziness, or tiredness may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly. People using this medication may have serious side effects. However, you have been prescribed this drug because your doctor has judged that the benefit to you is greater than the risk of side effects. Careful monitoring by your doctor may decrease your risk. Get medical help right away if you have any very serious side effects, including: vision changes (such as blurred vision, seeing flashes of light). A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345. |
| Storage | STORAGE: Store in the original package at room temperature away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company. |
| Storage | 04/23/2021 |
| Storage | 04/23/2021 |
| Uses | - |
| Uses | - |
| Uses | USES: Abrocitinib is used to treat a certain moderate-to-severe skin rash (dermatitis) that is not controlled with other treatments. Abrocitinib belongs to a class of drugs known as Janus kinase (JAK) inhibitors. |
Frequently Asked Questions (FAQs)
The cost of CIBINQO 100 MG TAB 30 is $available for registerd members only
CIBINQO 100 MG TAB 30 is manufactured by Pfizer.
You can purchase CIBINQO 100 MG TAB 30 on our website at https://supplies.pipelinemedical.com/product/detail/cibinqo-100-mg-tab-30-334323